Lilly launches Mounjaro in India for treatment of obesity and type 2 diabetes
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Announces Rs. 317 crore investment in new recycling plant
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
Subscribe To Our Newsletter & Stay Updated